Académique Documents
Professionnel Documents
Culture Documents
[citado
28
Mayo
2015];
27(4):23745.
http://www.scielosp.org/pdf/rpsp/v27n4/a01v27n4.pdf
Disponible
en:
52. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking
intervention on the incidence of coronary heart disease. Report from the Oslo study
group of a randomized trial in healthy men. Lancet 1981;2:1303-10.
53.Koch E, Romero T, Manrquez L, Paredes M, Ortzar E, Taylor A, et al.
Desigualdad educacional y socioeco- nmica como determinante de la mortalidad
en Chile: anlisis de sobrevida en la cohorte del proyecto San Francisco. Rev Md
Chile 2007;135:1370-9.
54. Jamerson K, Bakris GL, Dahlf B, Pitt B, Velazquez E, Gupte J, et al.
Exceptional early blood pressure control rates: the ACCOMPLISH trial. Blood
Press. 2007;16(2):80-6.
55. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al.
Prevention of coronary heart disease with pravastatin in men with
hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl
J Med. 1995;333(20):1301-7.
56. WHO. The World Health Report 2008 - primary Health Care (Now More Than
Ever) [Internet]. [Consultado 2015 Oct 11]. Disponible en:
http://www.who.int/whr/2008/en/
57. Pearson TA, Blair R, Daniels SR, Eckel RH, Ekel RH, Fair JM, et al. AHA
Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002
Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult
Patients Without Coronary or Other Atherosclerotic Vascular Diseases. Circulation
2002; 106 388-91.
58. Fonarow GC, Gawlinski A, Moughrabi S, Tillish JH. Improved treatment of
coronary heart disease by implementation of a Cardiac Hospitalization
Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819-22.
59. Romero T. La rehabilitacin cardaca como primer paso en la Prevencin
Secundaria. Rev Md Chile 2000;128:787-98.
60. Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, et al.
Effects of torcetrapib on the progression of coronary atheros- clerosis. N Enl J Med
2007;356:1304-16.
61. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of
intensive glucose lowering in Type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
62. Ministerio de Salud y Proteccin Social. Colombia enfrenta epidemia de
enfermedades cardiovasculares y diabetes. [Internet]. [Consultado 2016 Abr 17].
Disponible en: https://www.minsalud.gov.co/Paginas/Colombia-enfrenta-epidemiade-enfermedades-cardiovasculares-y-diabetes.aspx
63. Varela EA. Epidemiologa de la enfermedad cardiovascular. Bases
fundamentales de la cardiologa. [internet]. [Citado 17 abril 2016];
http://scc.org.co/wp-content/uploads/2012/08/capitulo-1.pdf
64. Secretaria de salud. Subsecretaria de prevencin y proteccin de la salud.
Programa de Accin: Enfermedades Cardiovasculares e Hipertensin Arterial.
[internet].
[Citado
17
abril]
2016]:
http://www.salud.gob.mx/unidades/cdi/documentos/enf_cardiovasculares.pdf
65. Segura A, Marrugat J. Epidemiologa cardiovascular. Libro de la salud
cardiovascular.
[internet].
[Citado
17
abril]
2016]:
http://www.fbbva.es/TLFU/microsites/salud_cardio/mult/fbbva_libroCorazon_cap10
.pdf
66. Manrique Abril Fred Gustavo, Ospina Daz Juan Manuel, Herrera Amaya
Giomar Maritza. Prevalencia de factores de riesgo para enfermedades
cardiovasculares en Tunja, Colombia. 2007. Investig. andina [Internet]. 2011 Sep
[citado 17 abril
2016] ;
13( 23 ): 312-322. Available from:
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S012481462011000200007&lng=en
67. Baena JM, Garca JL, Pelegrina JT, Martnez JL, Peacoba RM, Tejn IG,
Raid EM, Pomares M, Boronat AA, Prez BA, Forcadell PP, Espaa MR, Oller M.
Epidemiologa de las enfermedades cardiovasculares y factores de riesgo en
atencin primaria. [internet]. [citado 17 abril 2016]
Rev Esp Cardiol
2005;58(4):00-00
ftp://colbun.utalca.cl/profesores/gicaza/Respaldo%20FONIS
%20RCV/Marrugat/Baena%20JM%20Epi%20FRCV%20REC%202005.pdf
68. Organizacin Panamericana de la Salud. Colombia: perfil de las enfermedades
cardiovasculares.
[internet].
[citado
17
abril 2016]:
http://www.paho.org/hq/index.php?
option=com_docman&task=doc_download&Itemid=270&gid=27472&lang=es.
69. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones
JD, Materson BJ, Oparil S, Wright JT, Roccella ER, and the National High Blood
Pressure Education Program Coordinating Committee. Seventh report of the joint
national committee on prevention, detection, evaluation, and treatment of high
blood pressure. JNC 7 complete versin. American Heart Association, Inc, 2003.
70. James PA, Oparil S, Carter BL, PharmD; Cushman WC, Himmelfarb CD,
Handler J, MD; Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC,
Svetkey LP, Taler SJ, Townsend RR, Wright JT, Narva AS, Ortiz EO. 2014
Evidence-Based Guideline for the Management of High Blood Pressure in Adults
Report From the Panel Members Appointed to the Eighth Joint National Committee
(JNC 8). Clinical Review & Education. American Medical Association. 2013.
71. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M,
Christiaens T, Cifkova R, Backer G, Dominiczak A, Galderisi M, Grobbee DE,
Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope
LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, BernardWaeber, Zannad F.
The Task Force for the management of arterial hypertension of the European
Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
2013 ESH/ESC Guidelines for themanagement of arterial hypertension. ESH AND
ESC GUIDELINES. European Heart Journal (2013) 34, 21592219.
72. Basile J, Bloch MJ. Overview of hypertension in adults. Mar 02,2016.
73. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K,
Falk V, Filippatos G, Fonseca C, Gomez MG, Jaarsma T, Kober L, Lip GY,
Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH,
Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A.
Guia de practica clinica de la ESC sobre diagnostico y tratamiento de la
insuficiencia cardiaca aguda y cronica 2012. Rev Esp Cardiol. 2012;65(10):938.e1e59
74. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors
for congestive heart failure in US men and women. NHANES I Epidemiologogic
follow-up study. Arch Intern Med. 2001;161-1002
75. Vasan RS, Wilson PW. Epidemiology and causes of heart failure. Jul 23, 2015.
76. Djouss L, Driver JA, Gaziano JM. Relation between Modifiable Lifestyle
Factors and Lifetime Risk of Heart Failure: The Physicians Health Study I. JAMA.
2009 July 22; 302(4): 394400.
77. Majid A, Zemke DB, Kassab M. Pathophysiology of ischemic stroke. Sep 23,
2015.
78. Hennekens CH. Overview of primary prevention of coronary heart disease and
stroke. Apr 15, 2016.
79. Hennekens CH. Benefits and risks of aspirin in secondary and primary
prevention of cardiovascular disease. Jul 28, 2014.
80. Filho JM. Initial assessment and management of acute stroke. Dec 09, 2015.
81. Jauch EC, Saver JL, Chair V, Adams HP, Bruno A, Connors JJ, Demaerschalk
BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, Summers DR,
Wang DZ, Wintermark M, Yonas H. Guidelines for the Early Management of
Patients With Acute Ischemic Stroke: Executive Summary. A Guideline for
Healthcare Professionals From the American Heart Association/American Stroke
Association. 2013.
82. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third
Universal Definition of Myocardial Infarction. The European Society of Cardiology,
American College of Cardiology Foundation, American Heart Association, Inc., and
the World Heart Federation. 2012.
83. Reeder GS, Awtry E, Mahler SA. Initial evaluation and management of
suspected acute coronary syndrome (myocardial infarction, unstable angina) in the
emergency department. Dec 18, 2015.
84. Steg G, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, Di Mario C,
Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen
S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M,
Hof A, Widimsky P, Zahger D. Guia de practica clinica de la ESC para el manejo
del infarto agudo de miocardio en pacientes con elevacion del segmento ST.
Sociedad Espaola de Cardiologa. 2012.
85. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ,.
Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti
P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S.Gua ESC 2015
sobre el tratamiento de los sindromes coronarios agudos en pacientes sin
elevacin persistente del segmento ST. Rev Esp Cardiol. 2015;68(12):1125
86. Lalonde M, Minister of National Helath and Welfare [Internet]. [Consultado
2015 Oct 18]. Disponible en:
http://www.promocion.salud.gob.mx/dgps/descargas1/promocion/informelalonde.pdf
87. Conferencia Internacional sobre Atencin Primaria de Salud. Declaracin de
Alma-Ata [Internet]. [Consultado 2015 Oct 18]. Disponible en:
http://www.promocion.salud.gob.mx/dgps/descargas1/promocion/1_declaracion_de
ALMA_ATA.pdf
88. Primera Conferencia Internacional sobre la Promocin de la Salud. Carta de
Otawa [Internet]. [Consultado 2015 Oct 18]. Disponible en:
http://www.promocion.salud.gob.mx/dgps/descargas1/promocion/2_carta_de_otta
wa.pdf
89. Cuarta Conferencia Internacional sobre Promocin de la Salud. Declaracin de
Yakarta sobre la Promocin de la Salud en el Siglo XXI [Internet]. [Consultado
2015 Oct 18]. Disponible en:
http://www.promocion.salud.gob.mx/dgps/descargas1/promocion/5_Declaracion_d
e_Yakarta.pdf
90. OMS. Salud para todos en el siglo XXI [Internet]. [Consultado 2015 Oct 18].
Disponible en: http://apps.who.int/gb/archive/pdf_files/EB101/pdfspa/spa8.pdf
91. OPS. CARMEN - Conjunto de Acciones para la Reduccin Multifactorial de las
Enfermedades Crnicas no Transmisibles [Internet]. [Consultado 2015 Oct 18].
Disponible en:
https://www.google.com.co/url?
sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0CCMQFjAAah
UKEwiKrYr7iPvIAhUEYiYKHTY9AM4&url=http%3A%2F%2Fwww.paho.org
%2Fmex%2Findex.php%3Foption%3Dcom_docman%26task%3Ddoc_download
%26gid%3D517%26Itemid
%3D&usg=AFQjCNE6lxfSk99UfonApq3u6H39HASSnw&sig2=eKsT2YRKMY0bK5j
BHAQmoA
92. Colombia. Constitucin poltica de Colombia 1991.
93. Colombia. Ministerio de la Proteccin Social. Documento Conpes Social 113:
Poltica Nacional de Seguridad Alimentaria y Nutricional. (Maz. 31 de 2007).
94. Colombia. Ministerio de Salud y Proteccin Social. Plan Decenal de Salud
Pblica 2012-2021. (Mar. 15 de 2013).
95. Colombia. Congreso de la Repblica. Ley 9 de 1979 por la cual se dictan
Medidas Sanitarias. (Ene. 24 de 1979).